BioCrude Technologies USA, Inc.
CIK 0001690384
Revenue (TTM)
$0
Q1 May 2026
Net Income (TTM)
−$179.85K
+29.7% YoY
Q1 May 2026
EPS Diluted (TTM)
$0.00
+100.0% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$140.47K
Q1 May 2026
Cash
$1.78K
Q1 May 2026
Total Debt
$261.38K
Q1 May 2026
Shares Outstanding
50.87M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.